Advertisement

Reactions Weekly

, Volume 1729, Issue 1, pp 73–73 | Cite as

Cetuximab/paclitaxel

Septicaemia and pulmonary embolism: 2 case reports
Case report
  • 22 Downloads

Reference

  1. Enokida T, et al. Paclitaxel plus cetuximab as 1st line chemotherapy in platinum-based chemoradiotherapy-refractory patients with squamous cell carcinoma of the head and neck. Frontiers in Oncology 8: 339, 27 Aug 2018. Available from: URL: http://doi.org/10.3389/fonc.2018.00339 - JapanCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations